CCR5 receptor antagonists: Discovery and SAR study of guanylhydrazone derivatives

This publication has 17 references indexed in Scilit:

• Maraviroc
  Drugs of the Future, 2005
• Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor
  Bioorganic & Medicinal Chemistry Letters, 2004
• Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-{2-methoxy-1(R)-4-(trifluoromethyl)phenyl}ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist
  Journal of Medicinal Chemistry, 2004
• Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment
  Bioorganic & Medicinal Chemistry Letters, 2004
• Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains
  Bioorganic & Medicinal Chemistry Letters, 2004
• Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds
  Bioorganic & Medicinal Chemistry Letters, 2004
• Three-dimensional quantitative structure–activity relationship analyses of piperidine-based CCR5 receptor antagonists
  Bioorganic & Medicinal Chemistry, 2003
• Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides
  Bioorganic & Medicinal Chemistry Letters, 2003
• Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides
  Bioorganic & Medicinal Chemistry Letters, 2003
• Chemokines and HIV–1 second receptors
  Nature Medicine, 1996